Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Day: December 17, 2025

Neuroscience

Neuroscience Today — December 17, 2025

This week’s Neuroscience update features regulatory decisions, pipeline…

Immunology

Immunology Video Recap—December 17, 2025

This biweekly video brings you key highlights from across the immunology…

Immunology

Immunology Today—December 17, 2025

This week in immunology: the latest clinical updates, industry progress, and…

Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap —December 17, 2025

Here’s your biweekly AI in Healthcare and Digital Health video brief covering…

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in Alzheimer's

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in…

by Timos Papagatsias

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Insight Health $11 million Series A to focus on AI clinical agents
Lucid Diligence Brief: Stipple Bio $100 million Series A
Lucid Diligence Brief: Syneron Bio completion of $150 million Series B
Vaccines Today—April 3, 2026
Public Health Today—April 3, 2026

Tags

AC Immune AMONDYS 45 antisense oligonucleotide Behcet’s disease Bivamelagon Cardiac Rehab Cardiovascular Risk CGRP chronic disease prevention clinical operations Committee for Medicinal Products for Human Use Competitive Intelligence Process Copiktra delivery Dermatomyositis Duchenne MD Duvakitug ESC2025 Exosome Vaccines GLP1 drugs healthcare tech hospital technology IgG4 Related Disease KRAS Lifileucel Macular degeneration Mantle Cell Lymphoma med tech Medtronic Diabetes Metformin Microplastics microRNA neurosymbolic AI Nutrition Science OM336 pediatric rare disease RelabotulinumtoxinA robotic surgery RRMS Sarepta Therapeutics Serbian SCAD Registry Sjögrens Disease Sonelokimab Tabelecleucel Women’s heart health

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Insight Health $11 million Series A to focus on AI clinical agents
Lucid Diligence Brief: Stipple Bio $100 million Series A
Lucid Diligence Brief: Syneron Bio completion of $150 million Series B
Vaccines Today—April 3, 2026
Public Health Today—April 3, 2026

TAGS

AC Immune AMONDYS 45 antisense oligonucleotide Behcet’s disease Bivamelagon Cardiac Rehab Cardiovascular Risk CGRP chronic disease prevention clinical operations Committee for Medicinal Products for Human Use Competitive Intelligence Process Copiktra delivery Dermatomyositis Duchenne MD Duvakitug ESC2025 Exosome Vaccines GLP1 drugs healthcare tech hospital technology IgG4 Related Disease KRAS Lifileucel Macular degeneration Mantle Cell Lymphoma med tech Medtronic Diabetes Metformin Microplastics microRNA neurosymbolic AI Nutrition Science OM336 pediatric rare disease RelabotulinumtoxinA robotic surgery RRMS Sarepta Therapeutics Serbian SCAD Registry Sjögrens Disease Sonelokimab Tabelecleucel Women’s heart health

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy